Resting Energy Needs in Brain Dead Patients (reSting EneRgy nEeds iN brAin DEad Patients)

NCT05070182 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 66

Last updated 2021-10-07

No results posted yet for this study

Summary

The study will examine the resting energy need (REE) in patients suffering from brain damage. For the measurement of REE will be used a metabolic computer (which with continuous recording of breath-to-breath volume (Vt), respiratory rate (RR) of ventilation per minute volume (MV) ), of inhaled and exhaled gases (O2 and CO2) has the ability to calculate the values of VO2, VCO2 and with the help of equations the values of REE and RQ.

Conditions

  • Brain Death
  • Brain Injuries
  • Brain Edema
  • Brain Hemorrhage

Interventions

DIAGNOSTIC_TEST

REE - Resting Energy Expenditure

REEs represent 60-70% of the needs for a sedentary person and 50% of physically active people. For the measurement of REE will be used the metabolic computer (Medical Graphics, Ultima CCM, Minneapolis, USA), which with continuous recording of breath-to-breath volume (Vt), respiratory rate (RR) of ventilation per minute volume (MV) ), of inhaled and exhaled gases (O2 and CO2) has the ability to calculate the values of VO2, VCO2 and with the help of equations the values of REE and RQ. All patients in the study will be monitored with the metabolic computer. Their measurements will be recorded every day during their stay in the ICU.

DIAGNOSTIC_TEST

Transcranial Doppler

The measurement of flow velocities in the middle cerebral artery will be done with the transcranial Doppler using a low frequency (2 MHz) ultrasound head. All patients entering the study will be examined with the TCD every day during their stay in the ICU.

Sponsors & Collaborators

  • Papageorgiou General Hospital

    collaborator OTHER
  • Aristotle University Of Thessaloniki

    lead OTHER

Principal Investigators

  • Chryssa Pourzitaki, MD, PhD · Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2020-06-30
Completion
2020-12-30

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05070182 on ClinicalTrials.gov